Key Points
- The UK Symposium on Neuromodulation and Neurotechnology was held September 12–13 in Nottingham, UK.
- Four presentations featured focused ultrasound neuromodulation for various applications, including psychiatric and cognitive disorders.
The UK Symposium on Neuromodulation and Neurotechnology, held September 12–13, 2024, in Nottingham, brought together an international group of researchers, clinicians, and industry experts to discuss the latest developments and challenges in the neuromodulation space. The symposium was co-hosted by Neuromod+ and CloseNIT, two research networks built to support the growth of neuromodulation technologies.
Several presentations highlighted focused ultrasound neuromodulation as a treatment for substance use disorder, psychiatric diseases, and more.
Focused Ultrasound Presentations
Plenary Talk chaired by Simon Schultz
- Exploring Low-Intensity Focused Ultrasound as a Treatment Strategy for Substance Use Disorder by Daisy Thompson-Lake, West Virginia University
Public Involvement in Neurotechnology
- Introduction to Neuromodulation, Public Attitudes to Neuromodulation by Marcus Kaiser, University of Nottingham
Network Research Showcase – Cognitive Disorders chaired by Ashwini Oswal
- Transcranial Ultrasound Stimulation to the Human Amygdala in Emotion and Decision Making by Miriam Klein-Flügge, University of Oxford
- Enhancing Semantic Memory with Transcranial Focused Ultrasound Stimulation of the Anterior Temporal Lobe by JeYoung Jung, University of Nottingham